Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management
Top Cited Papers
- 1 January 2010
- journal article
- practice guideline
- Published by Elsevier BV in The Lancet Neurology
- Vol. 9 (1), 77-93
- https://doi.org/10.1016/s1474-4422(09)70271-6
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Technology Insight: therapy for Duchenne muscular dystrophy—an opportunity for personalized medicine?Nature Clinical Practice Neurology, 2008
- Psychosocial Adjustment in Males with Duchenne Muscular Dystrophy: Psychometric Properties and Clinical Utility of a Parent-report QuestionnaireJournal of Pediatric Psychology, 2007
- Delayed Developmental Language Milestones in Children with Duchenne’s Muscular DystrophyThe Journal of Pediatrics, 2007
- Are Males With Duchenne Muscular Dystrophy at Risk for Reading Disabilities?Pediatric Neurology, 2006
- Proposals for prevention and management of steroid‐induced osteoporosis in children and adolescentsJournal of Paediatrics and Child Health, 2005
- Experience and Strategy for the Molecular Testing of Duchenne Muscular DystrophyThe Journal of Molecular Diagnostics, 2005
- Depression in parents of children with duchenne muscular dystrophyPediatric Neurology, 2004
- Neonatal Screening for Duchenne Muscular Dystrophy: A Novel Semiquantitative Application of the Bioluminescence Test for Creatine Kinase in a Pilot National Program in CyprusGenetic Testing, 1998
- Randomized, Double-Blind Six-Month Trial of Prednisone in Duchenne's Muscular DystrophyThe New England Journal of Medicine, 1989
- Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individualsCell, 1987